- Home
- IKT vs OXSQ Comparison
IKT vs OXSQ Comparison
Compare IKT & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- OXSQ
- Stock Information
- Founded
- IKT 2008
- OXSQ 2003
- Country
- IKT United States
- OXSQ United States
- Employees
- IKT N/A
- OXSQ N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- OXSQ Blank Checks
- Sector
- IKT Health Care
- OXSQ Finance
- Exchange
- IKT Nasdaq
- OXSQ Nasdaq
- Market Cap
- IKT 140.5M
- OXSQ 168.6M
- IPO Year
- IKT 2020
- OXSQ N/A
- Fundamental
- Price
- IKT $1.56
- OXSQ $2.07
- Analyst Decision
- IKT Buy
- OXSQ
- Analyst Count
- IKT 2
- OXSQ 0
- Target Price
- IKT $8.00
- OXSQ N/A
- AVG Volume (30 Days)
- IKT 92.1K
- OXSQ 702.7K
- Earning Date
- IKT 11-13-2025
- OXSQ 11-04-2025
- Dividend Yield
- IKT N/A
- OXSQ 20.29%
- EPS Growth
- IKT N/A
- OXSQ N/A
- EPS
- IKT N/A
- OXSQ N/A
- Revenue
- IKT N/A
- OXSQ $40,243,556.00
- Revenue This Year
- IKT N/A
- OXSQ N/A
- Revenue Next Year
- IKT N/A
- OXSQ N/A
- P/E Ratio
- IKT N/A
- OXSQ N/A
- Revenue Growth
- IKT N/A
- OXSQ N/A
- 52 Week Low
- IKT $1.12
- OXSQ $2.06
- 52 Week High
- IKT $4.20
- OXSQ $2.99
- Technical
- Relative Strength Index (RSI)
- IKT 42.51
- OXSQ 22.92
- Support Level
- IKT $1.50
- OXSQ $2.18
- Resistance Level
- IKT $1.73
- OXSQ $2.20
- Average True Range (ATR)
- IKT 0.09
- OXSQ 0.04
- MACD
- IKT -0.02
- OXSQ -0.01
- Stochastic Oscillator
- IKT 17.34
- OXSQ 5.88
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.